(-)-TERPINEN-4-OL

CAS No. 20126-76-5

(-)-TERPINEN-4-OL ( —— )

Catalog No. M23903 CAS No. 20126-76-5

Terpinen-4-ol can be used as an antibacterial and antibiofilm agent against Staphylococcus aureus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (-)-TERPINEN-4-OL
  • Note
    Research use only, not for human use.
  • Brief Description
    Terpinen-4-ol can be used as an antibacterial and antibiofilm agent against Staphylococcus aureus.
  • Description
    Terpinen-4-ol can be used as an antibacterial and antibiofilm agent against Staphylococcus aureus.
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20126-76-5
  • Formula Weight
    154.3
  • Molecular Formula
    C10H18O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)[C@@]1(CC=C(C)CC1)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cordeiro L, Figueiredo P, Souza H, Sousa A, Andrade-Júnior F, Medeiros D, Nóbrega J, Silva D, Martins E, Barbosa-Filho J, Lima E. Terpinen-4-ol as an Antibacterial and Antibiofilm Agent against Staphylococcus aureus. Int J Mol Sci. 2020 Jun 25;21(12):4531.
molnova catalog
related products
  • PGLa

    PGLa is a cationic antimicrobial peptide (AMP) originally isolated from frog. It has been shown to have antibacterial,antifungal,and antiviral,activities.

  • Ceftobiprole

    Ceftobiprole is a broad-spectrum cephalosporin with activity against Methicillin-resistant staphylococcus aureus.

  • PAβN dihydrochloride

    PAβN dihydrochloride is an inhibitor of efflux pump. PAβN reduces the MICs in nine ciprofloxacin-resistant isolates, and in four of these, PAβN increases the susceptibility by twofold.?